Intellipharmaceutics International Price on June 16, 2023
IPCIFDelisted Stock | USD 0.04 0.00 0.00% |
If you're considering investing in Intellipharmaceutics OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Intellipharmaceutics stands at 0.04, as last reported on the 12th of December 2024, with the highest price reaching 0.04 and the lowest price hitting 0.04 during the day. We have found twenty-four technical indicators for Intellipharmaceutics, which you can use to evaluate the volatility of the firm. Please check out Intellipharmaceutics' Risk Adjusted Performance of 0.1305, market risk adjusted performance of (0.62), and Downside Deviation of 48.71 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
Intellipharmaceutics OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Intellipharmaceutics |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
IPCIF |
Based on monthly moving average Intellipharmaceutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intellipharmaceutics by adding Intellipharmaceutics to a well-diversified portfolio.
Intellipharmaceutics Valuation on June 16, 2023
It is possible to determine the worth of Intellipharmaceutics on a given historical date. On June 16, 2023 Intellipharmaceutics was worth 0.05 at the beginning of the trading date compared to the closed value of 0.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Intellipharmaceutics otc stock. Still, in general, we apply an absolute valuation method to find Intellipharmaceutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Intellipharmaceutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Intellipharmaceutics' related companies.
Open | High | Low | Close | Volume | |
0.06 | 0.06 | 0.06 | 0.06 | 1,000.00 | |
06/16/2023 | 0.05 | 0.05 | 0.05 | 0.05 | 1,300 |
0.05 | 0.05 | 0.05 | 0.05 | 1.00 |
Backtest Intellipharmaceutics | | | Intellipharmaceutics History | | | Intellipharmaceutics Valuation | Previous | Next |
Intellipharmaceutics Trading Date Momentum on June 16, 2023
On June 20 2023 Intellipharmaceutics International was traded for 0.05 at the closing time. The highest daily price throughout the period was 0.05 and the lowest price was 0.05 . There was no trading activity during the period 1.0. Lack of trading volume on 06/20/2023 did not cause price change. The trading delta at closing time to current closing price is 40.00% . |
Intellipharmaceutics Fundamentals Correlations and Trends
By evaluating Intellipharmaceutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Intellipharmaceutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Intellipharmaceutics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Intellipharmaceutics OTC Stock history
Intellipharmaceutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Intellipharmaceutics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Intellipharmaceutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Intellipharmaceutics stock prices may prove useful in developing a viable investing in Intellipharmaceutics
Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. The company was founded in 1998 and is based in Toronto, Canada. Intellipharmaceutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 11 people.
Intellipharmaceutics OTC Stock Technical Analysis
Intellipharmaceutics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Intellipharmaceutics Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Intellipharmaceutics International cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Intellipharmaceutics December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Intellipharmaceutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intellipharmaceutics shares will generate the highest return on investment. By undertsting and applying Intellipharmaceutics otc stock market strength indicators, traders can identify Intellipharmaceutics International entry and exit signals to maximize returns
Intellipharmaceutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Intellipharmaceutics' price direction in advance. Along with the technical and fundamental analysis of Intellipharmaceutics OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Intellipharmaceutics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1305 | |||
Jensen Alpha | 15.93 | |||
Total Risk Alpha | 0.6756 | |||
Sortino Ratio | 0.2746 | |||
Treynor Ratio | (0.63) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |